Bhat Fayaz Ahmad, Changal Khalid Hamid, Raina Hameed, Tramboo Nisar Ahmad, Rather Hilal Ahmad
Internal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
Present affiliation: Mercy St. Vincent's Medical Center, Toledo, OH, USA.
BMC Cardiovasc Disord. 2017 Jan 11;17(1):23. doi: 10.1186/s12872-016-0457-2.
PCI has been done traditionally through transfemoral route. But now transradial and transbrachial routes are also coming up in practice. We compared transradial versus transfemoral routes for ease of operability, time for procedure, complications, and failure rates through a prospective study.
Four hundred Patients admitted in department of cardiology for percutaneous interventions were enrolled in the study. 200 patients were assigned to each group randomly. A single team did all the procedures. Pre procedure, intra procedure and post procedure data of all the patients was collected, tabulated and analysed properly.
Access time (6.0 ± 1vs 4.2 ± 0.7; P =0.001); Fluoroscopy time and overall procedure time (29 ± 11.3 Vs. 27.3 ± 12.4 min) were more with trans radial than transfemoral route, respectively. The most common post procedure complication, ecchymosis was seen in 20.5% in transfemoral group compared to 12.5% in transradial group (P 0.031). Thrombophelibites (17.5 VS 8%, P0.004); Hematoma (14.5 Vs 0%, P 0.005); post procedure access bleed (7 VS 3%, P 0.039) were seen in transfemoral than transradial group, respectively. Failure rates were almost similar. None of our patients had post procedure myocardial infarction, stroke, acute renal failure and infections.
Transradial approach of PCI is better than transfemoral route with respect to complications like bleeding, haematoma formation, thrombophelebites and ecchymosis is concerned. However access and fluoroscopic time is more with the former. We recommend the transradial route for PCI.
Trial is retrospectively registered in ClinicalTrials.gov with the Identifier: NCT02983721 , Date of registration is December 2, 2016.
传统上经皮冠状动脉介入治疗(PCI)是通过股动脉途径进行的。但现在经桡动脉和经肱动脉途径在实际操作中也逐渐兴起。我们通过一项前瞻性研究比较了经桡动脉与经股动脉途径在操作便利性、手术时间、并发症及失败率方面的差异。
心内科收治的400例接受经皮介入治疗的患者纳入本研究。每组随机分配200例患者。所有手术均由同一团队完成。收集所有患者术前、术中和术后的数据,进行列表并妥善分析。
桡动脉途径的穿刺时间(6.0±1对4.2±0.7;P = 0.001);透视时间和总手术时间(29±11.3对27.3±12.4分钟)均比股动脉途径更长。术后最常见的并发症,瘀斑在股动脉组中为20.5%,而桡动脉组为12.5%(P = 0.031)。股动脉组的血栓性浅静脉炎(17.5%对8%,P = 0.004);血肿(14.5%对0%,P = 0.005);术后穿刺部位出血(7%对3%,P = 0.039)均高于桡动脉组。失败率几乎相似。我们的患者均未发生术后心肌梗死、中风、急性肾衰竭和感染。
就出血、血肿形成、血栓性浅静脉炎和瘀斑等并发症而言,PCI的经桡动脉途径优于经股动脉途径。然而,前者的穿刺和透视时间更长。我们推荐PCI采用经桡动脉途径。
该试验在ClinicalTrials.gov上进行回顾性注册,标识符为:NCT02983721,注册日期为2016年12月2日。